A randomized, open label study to evaluate the effect of Tamiflu on viral shedding and on serum and cytoplasmic inflammatory cytokine concentrations in patients with laboratory-confirmed influenza.
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 23 Feb 2010 Actual initiation date (Jan 2007) added as reported by Roche record.
- 20 Mar 2007 New trial record.